Alberta Investment Management Corp (AIMCo)’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-17,700
| Closed | -$4.78M | – | 469 |
|
|
2025
Q1 | $4.78M | Sell |
17,700
-300
| -2% | -$81K | 0.03% | 292 |
|
|
2024
Q4 | $4.24M | Buy |
18,000
+11,100
| +161% | +$2.61M | 0.03% | 311 |
|
|
2024
Q3 | $1.9M | Buy |
+6,900
| New | +$1.9M | 0.02% | 442 |
|
|
2024
Q2 | – | Sell |
-2,900
| Closed | -$433K | – | 713 |
|
|
2024
Q1 | $433K | Sell |
2,900
-4,275
| -60% | -$639K | ﹤0.01% | 840 |
|
|
2023
Q4 | $1.37M | Buy |
7,175
+4,275
| +147% | +$818K | 0.01% | 544 |
|
|
2023
Q3 | $514K | Hold |
2,900
| – | – | 0.01% | 807 |
|
|
2023
Q2 | $551K | Hold |
2,900
| – | – | 0.01% | 918 |
|
|
2023
Q1 | $581K | Buy |
+2,900
| New | +$581K | 0.01% | 931 |
|
|
2021
Q3 | – | Sell |
-84,800
| Closed | -$14.4M | – | 961 |
|
|
2021
Q2 | $14.4M | Sell |
84,800
-4,000
| -5% | -$678K | 0.12% | 188 |
|
|
2021
Q1 | $12.5M | Sell |
88,800
-5,500
| -6% | -$777K | 0.11% | 197 |
|
|
2020
Q4 | $12.3M | Buy |
94,300
+13,300
| +16% | +$1.73M | 0.11% | 217 |
|
|
2020
Q3 | $11.8M | Buy |
81,000
+10,500
| +15% | +$1.53M | 0.13% | 189 |
|
|
2020
Q2 | $10.4M | Buy |
70,500
+18,500
| +36% | +$2.74M | 0.12% | 206 |
|
|
2020
Q1 | $5.66M | Hold |
52,000
| – | – | 0.1% | 241 |
|
|
2019
Q4 | $5.99M | Sell |
52,000
-11,400
| -18% | -$1.31M | 0.05% | 311 |
|
|
2019
Q3 | $5.1M | Sell |
63,400
-24,500
| -28% | -$1.97M | 0.05% | 332 |
|
|
2019
Q2 | $6.38M | Buy |
87,900
+27,900
| +47% | +$2.02M | 0.06% | 294 |
|
|
2019
Q1 | $5.61M | Buy |
+60,000
| New | +$5.61M | 0.05% | 296 |
|
|
2018
Q2 | – | Sell |
-56,200
| Closed | -$6.69M | – | 818 |
|
|
2018
Q1 | $6.69M | Buy |
56,200
+44,500
| +380% | +$5.3M | 0.06% | 297 |
|
|
2017
Q4 | $1.49M | Sell |
11,700
-7,500
| -39% | -$953K | 0.01% | 488 |
|
|
2017
Q3 | $2.26M | Buy |
+19,200
| New | +$2.26M | 0.02% | 443 |
|
|
2017
Q1 | – | Sell |
-14,900
| Closed | -$558K | – | 798 |
|
|
2016
Q4 | $558K | Buy |
+14,900
| New | +$558K | 0.01% | 593 |
|
|
2015
Q3 | – | Sell |
-7,200
| Closed | -$863K | – | 498 |
|
|
2015
Q2 | $863K | Buy |
+7,200
| New | +$863K | 0.01% | 469 |
|